DESCRIPTION
A 3-year-old girl presented with a 3-week history of headaches, unsteady gait and episodic vomiting. On neurological examination, she had gaze-evoked nystagmus, intermittent titubation and mild ataxic gait. MRI revealed a large posterior fossa tumour with reduced diffusivity and heterogeneous nodularappearing enhancement (figure 1). MRI of the spine and subsequent cerebrospinal fluid analysis were negative for disseminated disease. Following gross total resection, pathology demonstrated a malignant small blue cell neoplasm with anaplasia, nuclear pleomorphism and myxoid areas containing eosinophilic cells (figure 2). Immunohistochemistry (IHC) for myogenin revealed nuclear positivity in the myxoid areas consistent with a diagnosis of medullomyoblastoma. IHC revealed no loss of expression of INI-1, excluding a diagnosis of atypical teratoid rhabdoid tumour. Fluorescence in situ hybridisation for n-MYC amplification was negative. However, amplification of c-MYC was observed in almost 20% of cells, which showed amplification of chromosome 8 using centromeric probes.
The patient underwent craniospinal proton beam radiation therapy with adjuvant chemotherapy and remains in remission at 1 year postdiagnosis.
Medulloblastoma with myogenic differentiation, also sometimes referred to as medullomyoblastoma, is an extremely rare variant of medulloblastoma, characterised by neuroectodermal small blue cell tissue and rhabdomyoblastic tissue, which is confirmed by positive myogenin immunostaining and no loss of INI expression to exclude atypical teratoid rhabdoid tumour. Neuroimaging may demonstrate biphasic nodularity, corresponding pathologically to the different tissue types present within the neoplasm, which may differentiate medullomyoblastoma from classic medulloblastoma. 1 The presence of anaplastic features is associated with worse prognosis. 2 The molecular features of medullomyoblastoma are distinct from the four common 
Learning points
▸ Medulloblastoma with myogenic differentiation, sometimes referred to as medullomyoblastoma, is a very rare medulloblastoma variant; it may have a nodular appearance on postgadolinium MRI sequences, mimicking nodular desmoplastic medulloblastoma or atypical teratoid rhabdoid tumour. ▸ Medulloblastoma with myogenic differentiation does not fall into the current conventional molecular stratification schema of medulloblastoma and therefore far less is known about ideal management and long-term prognosis. ▸ The amplification of c-MYC through polyploidy/ hyperdiploid chromosome 8 complement is a novel form of non-focal amplification and worthy of further study in larger cohorts of similar tumours.
stratifications reported in medulloblastoma (wingless, sonic hedgehog, group 3, group 4), 3 adding further complexity to this extremely rare paediatric brain tumour. 
